FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to surgery and dermatology, more exactly to methods of treating pyoinflammatory diseases of skin, in particular erysipelatous inflammation, furunculosis, acne disease. For this purpose within complex therapy at the background of antibiotics, anti-inflammatory and desensitising medications medication Bestim is introduced for, at least, 5 days. Bestim is introduced per orally in day dose 0.3-1.5 mg during 10 days daily or intramuscularly in physiological solution in day dose 0.1 mg 5 times every second day or for 5 days daily.
EFFECT: method insures increase of therapy efficiency due to stimulation of T-helpers 17 functional activity.
4 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS SUFFERING PUSTULAR SKIN DISORDERS | 2012 |
|
RU2479308C1 |
MEANS OF PREVENTIVE MAINTENANCE AND TREATMENT OF THE PUSTULOUS DISEASES CAUSED BY BACTERIAL SKIN DEFEATS (VARIANTS) | 2010 |
|
RU2442566C2 |
METHOD FOR INDIVIDUAL PRESCRIPTION OF IMMUNOACTIVE PREPARATIONS IN TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2011 |
|
RU2480760C2 |
COMPOSITION BASED ON INTERFERON I OR III TYPE AND GAMMA-D-GLUTAMINYL-L-TRYPTOPHAN FOR PREVENTION AND TREATMENT OF INFECTIOUS DISEASES AND IMMUNODEFICIENCY CONDITIONS (OPTIONS) | 2014 |
|
RU2672861C2 |
METHOD OF TREATING PATIENTS SUFFERING FROM COMPLICATED FORMS OF ERYSIPELAS | 2014 |
|
RU2546039C1 |
ENZYMATIC WOUND HEALING MEDICATION | 2011 |
|
RU2484811C2 |
SODIUM AMINODIHYDROPHTHALAZINEDIONE SOLUTION FOR INTRAVENOUS ADMINISTRATION | 2023 |
|
RU2821033C1 |
METHOD OF SELECTING TACTICS OF TREATMENT OF ACUTE INFLAMMATORY DISEASES OF ORBIT | 2010 |
|
RU2435555C1 |
METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS | 2001 |
|
RU2229892C2 |
METHOD OF TREATMENT OF ERYTHEMATOUS-BULLOUS FORM OF ERYSIPELAS | 2023 |
|
RU2803130C1 |
Authors
Dates
2011-07-20—Published
2009-06-25—Filed